Ladislav Andera Selected Research

N(2)- (2- aminocyclohexyl)- N(6)- (3- chlorophenyl)- 9- ethyl- 9H- purine- 2,6- diamine

7/2014

CGP74514A enhances TRAIL-induced apoptosis in breast cancer cells by reducing X-linked inhibitor of apoptosis protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ladislav Andera Research Topics

Disease

24	Neoplasms (Cancer) 01/2022 - 03/2002
9	Colonic Neoplasms (Colon Cancer) 05/2012 - 11/2004
6	Leukemia 09/2021 - 01/2009
4	Breast Neoplasms (Breast Cancer) 01/2018 - 08/2005
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 09/2021
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 03/2016
2	Lymphoma (Lymphomas) 01/2022 - 02/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2018 - 01/2014
2	Melanoma (Melanoma, Malignant) 01/2017 - 01/2011
2	Necrosis 07/2013 - 09/2009
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2022
1	Genomic Instability 01/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019
1	Carcinoma (Carcinomatosis) 03/2016
1	Colorectal Neoplasms (Colorectal Cancer) 06/2013
1	Neoplasm Metastasis (Metastasis) 09/2011
1	Prostatic Neoplasms (Prostate Cancer) 01/2011
1	Tics (Tic) 01/2009
1	Polyps 03/2008
1	Malignant Mesothelioma 04/2006

Drug/Important Bio-Agent (IBA)

12	LigandsIBA 03/2018 - 03/2002
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2018 - 03/2002
7	Death Domain ReceptorsIBA 07/2013 - 09/2007
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2009
6	TNF-Related Apoptosis-Inducing LigandIBA 11/2013 - 08/2005
4	venetoclaxIBA 01/2022 - 03/2016
4	CytokinesIBA 03/2018 - 11/2005
3	HomoharringtonineIBA 03/2016 - 06/2013
3	Pharmaceutical PreparationsIBA 11/2013 - 01/2009
2	S63845IBA 01/2022 - 01/2019
2	Cytostatic AgentsIBA 09/2021 - 01/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2012
2	Tamoxifen FDA LinkGeneric 01/2019 - 01/2018
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 03/2018 - 06/2005
2	Small Interfering RNA (siRNA)IBA 03/2016 - 01/2014
2	CaspasesIBA 02/2013 - 01/2011
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2011 - 06/2005
1	Biomarkers (Surrogate Marker)IBA 09/2021
1	Apoptosis Regulatory ProteinsIBA 09/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Caspase 8 (Caspase-8)IBA 03/2018
1	Fulvestrant (Faslodex)FDA Link 01/2018
1	Red Fluorescent ProteinIBA 01/2017
1	Mitochondrial DNA (mtDNA)IBA 01/2017
1	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 03/2016
1	X-Linked Inhibitor of Apoptosis ProteinIBA 07/2014
1	N(2)- (2- aminocyclohexyl)- N(6)- (3- chlorophenyl)- 9- ethyl- 9H- purine- 2,6- diamineIBA 07/2014
1	EmetineIBA 01/2014
1	Protein Synthesis InhibitorsIBA 11/2013
1	CurcuminIBA 11/2013
1	AlkaloidsIBA 06/2013
1	AntibodiesIBA 06/2013
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2013
1	RoscovitineIBA 02/2013
1	Drug CombinationsIBA 05/2012
1	Choline KinaseIBA 05/2012
1	rac1 GTP-Binding ProteinIBA 09/2011
1	GTP Phosphohydrolases (GTPases)IBA 09/2011
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 09/2011
1	Cisplatin (Platino)FDA LinkGeneric 01/2011
1	PlatinumIBA 01/2011
1	PLX 4720IBA 01/2011
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2009
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2009
1	dispaseIBA 03/2008
1	Sequestering AgentsIBA 09/2007
1	Nystatin (Mycostatin)FDA LinkGeneric 09/2007
1	LipidsIBA 09/2007
1	FlavonoidsIBA 09/2007
1	QuercetinIBA 09/2007
1	CholesterolIBA 09/2007
1	Succinic Acid (Succinate)IBA 04/2006
1	Docosahexaenoic AcidsIBA 11/2005
1	Caspase 3 (Caspase-3)IBA 11/2005
1	Trastuzumab (Herceptin)FDA Link 08/2005
1	Mitogen-Activated Protein KinasesIBA 06/2005
1	Ethanol (Ethyl Alcohol)IBA 11/2004

Therapy/Procedure

13	Therapeutics 01/2022 - 06/2005
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2009